Variant report
Variant | nsv1034252 |
---|---|
Chromosome Location | chr8:6082798-6105092 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANGPT2-11 | chr8:6082847-6083064 | NONHSAT124769 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4841060 | chr8:6082798-6082799 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs552639451 | chr8:6082803-6082804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569209608 | chr8:6082819-6082820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536606879 | chr8:6082820-6082821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556552687 | chr8:6082845-6082846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573372867 | chr8:6082849-6082850 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs574963069 | chr8:6082852-6082853 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs191147530 | chr8:6082855-6082856 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs553124503 | chr8:6082860-6082861 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs573000285 | chr8:6082868-6082869 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs545193010 | chr8:6082916-6082917 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs182262511 | chr8:6082925-6082926 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs575628446 | chr8:6082964-6082965 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs202167536 | chr8:6082968-6082969 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs185495315 | chr8:6082980-6082981 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs78768559 | chr8:6082981-6082982 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs564091116 | chr8:6083007-6083008 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs143884696 | chr8:6083032-6083033 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs148155072 | chr8:6083038-6083039 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs115910397 | chr8:6083040-6083041 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs532548374 | chr8:6083046-6083047 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs142015260 | chr8:6083068-6083069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532835991 | chr8:6083070-6083071 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531904398 | chr8:6083073-6083074 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146164718 | chr8:6083078-6083079 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547251876 | chr8:6083086-6083087 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566964334 | chr8:6083111-6083112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75524549 | chr8:6083129-6083130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552747773 | chr8:6083139-6083140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566572313 | chr8:6083149-6083150 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538423709 | chr8:6083172-6083173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558811961 | chr8:6083187-6083188 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374750886 | chr8:6083199-6083200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140126926 | chr8:6083200-6083201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554991342 | chr8:6083201-6083202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574930645 | chr8:6083206-6083207 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17076285 | chr8:6083209-6083210 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs560342065 | chr8:6083217-6083218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532654361 | chr8:6083218-6083219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189856404 | chr8:6083219-6083220 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74443241 | chr8:6083244-6083245 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs73190726 | chr8:6083248-6083249 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs569088612 | chr8:6083258-6083259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548518167 | chr8:6083259-6083260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549167199 | chr8:6083280-6083281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs75960905 | chr8:6083300-6083301 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs77099590 | chr8:6083332-6083333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546592085 | chr8:6083353-6083354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143826149 | chr8:6083361-6083362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182802743 | chr8:6083367-6083368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6081400-6087800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
2 | chr8:6081800-6082800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr8:6082400-6084600 | Weak transcription | Fetal Brain Male | brain |
4 | chr8:6084600-6087200 | Enhancers | Fetal Brain Male | brain |
5 | chr8:6086800-6087800 | Enhancers | Pancreas | Pancrea |
6 | chr8:6087000-6087800 | Enhancers | Esophagus | oesophagus |
7 | chr8:6087000-6088400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr8:6087000-6089000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr8:6100200-6100600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr8:6104000-6105600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr8:6104000-6106000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr8:6104400-6107400 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr8:6104800-6105200 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr8:6105000-6107400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |